Save up to 90% on Qulipta with Coupons, Discount Cards & Patient Assistance Programs

Qulipta is the brand name for atogepant and is available as an oral tablet.

Qulipta is available as 10 mg, 30 mg, and 60 mg oral tablet.

• Qulipta is a calcitonin gene-related peptide (CGRP) receptor blocker that is used in the prevention of migraines in adults

Qulipta is a calcitonin gene-related peptide (CGRP) receptor blocker. This means it blocks a protein called CGRP in the brain and nervous system. CGRP is thought to be involved with migraines and causing inflammation and pain. By blocking the protein’s activity, Qulipta can help prevent migraine attacks.

Qulipta is typically dosed as follows:

• Episodic migraines (migraines that occur on fewer than 15 days per month): The typical dose is 10 mg, 30 mg, or 60 mg by mouth once per day
• Chronic migraines (migraines that occur on 15 or more days per month): The typical dose is 60 mg by mouth once per day
• Your dose might differ depending on whether you’re taking another medication that interacts with Qulipta and whether you have kidney problems

Qulipta is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you.

Common side effects of Qulipta:

• Nausea
• Constipation
• Fatigue or sleepiness
• Low appetite
• Dizziness

Serious side effects are rare with Qulipta. Contact your healthcare provider immediately if you experience any of the following.

• Serious allergic reaction: hives, rash, blisters, skin reddening, swelling of the lips or tongue, difficulty breathing

The following medications may interact with Qulipta:

• Recommended dosage modifications:
• Strong CYP3A4 Inhibitor:
• Episodic migraine: 10 mg once daily
• Chronic migraine: avoid use
• Strong, Moderate, or Weak CYP3A4 Inducers:
• Episodic migraine: 30 mg or 60 mg once daily
• Chronic migraine: avoid use
• OATP Inhibitors:
• Episodic migraine: 10 mg or 30 mg once daily
• Chronic migraine: 30 mg once daily

AbbVie Inc.

Based on animal data, Qulipta may cause fetal harm. You should talk to your healthcare provider before taking this medication if you are pregnant. Qulipta should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

• Atogepant